News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Landry Robert E
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/25/2023 |
4
| Landry Robert E (EVP Finance CFO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 223 shares
@ $844, valued at
$188.2k
|
|
| 08/23/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2023 |
4
| Landry Robert E (EVP Finance CFO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 739 shares
@ $764.5, valued at
$565k
Paid exercise price by delivering 2,248 shares
@ $774.29, valued at
$1.7M
Sold 51 shares
@ $783.05, valued at
$39.9k
Sold 113 shares
@ $784.27, valued at
$88.6k
Sold 78 shares
@ $785.88, valued at
$61.3k
Sold 85 shares
@ $786.45, valued at
$66.8k
Sold 58 shares
@ $787.47, valued at
$45.7k
Sold 99 shares
@ $788.62, valued at
$78.1k
Sold 49 shares
@ $789.05, valued at
$38.7k
Sold 10 shares
@ $790.41, valued at
$7.9k
Sold 3 shares
@ $791, valued at
$2.4k
|
|
| 12/20/2022 |
4
| Landry Robert E (EVP Finance CFO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Granted 3,853 shares
@ $0
Granted 14,222 options to buy
@ $726.53, valued at
$10.3M
|
|
| 12/12/2022 |
4
| Landry Robert E (EVP Finance CFO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 2,261 shares
@ $768.54, valued at
$1.7M
Paid exercise price by delivering 492 shares
@ $753.28, valued at
$370.6k
Exercised 3,000 options to buy
@ $381.92, valued at
$1.1M
|
|
| 10/18/2022 |
4
| Landry Robert E (EVP Finance CFO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 1,142 shares
@ $743.78, valued at
$849.4k
Sold 358 shares
@ $739.5, valued at
$264.7k
Exercised 1,500 options to buy
@ $381.92, valued at
$572.9k
|
|
| 04/11/2022 |
4
| Landry Robert E (EVP Finance CFO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 1,175 shares
@ $716.09, valued at
$841.4k
Sold 16 shares
@ $724.33, valued at
$11.6k
Sold 30 shares
@ $728.77, valued at
$21.9k
Sold 16 shares
@ $729.67, valued at
$11.7k
Sold 44 shares
@ $733.38, valued at
$32.3k
Sold 43 shares
@ $735.12, valued at
$31.6k
Sold 29 shares
@ $739.02, valued at
$21.4k
Sold 28 shares
@ $740.98, valued at
$20.7k
Sold 32 shares
@ $743.71, valued at
$23.8k
Sold 56 shares
@ $744.52, valued at
$41.7k
Sold 31 shares
@ $745.27, valued at
$23.1k
|
|
| 04/01/2022 |
4
| Landry Robert E (EVP Finance CFO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 1,184 shares
@ $700.99, valued at
$830k
Sold 301 shares
@ $695.5, valued at
$209.3k
Sold 15 shares
@ $701.98, valued at
$10.5k
Exercised 1,500 options to buy
@ $399.66, valued at
$599.5k
|
|
| 03/30/2022 |
4
| Landry Robert E (EVP Finance CFO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 1,134 shares
@ $685.26, valued at
$777.1k
Paid exercise price by delivering 3,183 shares
@ $685.26, valued at
$2.2M
Paid exercise price by delivering 3,581 shares
@ $685.26, valued at
$2.5M
Paid exercise price by delivering 2,785 shares
@ $685.26, valued at
$1.9M
Sold 54 shares
@ $681.9, valued at
$36.8k
Sold 103 shares
@ $682.37, valued at
$70.3k
Sold 304 shares
@ $683.29, valued at
$207.7k
Sold 227 shares
@ $684.45, valued at
$155.4k
Sold 176 shares
@ $685.58, valued at
$120.7k
Sold 192 shares
@ $686.67, valued at
$131.8k
Sold 220 shares
@ $687.52, valued at
$151.3k
|
|
| 03/23/2022 |
4
| Landry Robert E (EVP Finance CFO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 300 shares
@ $693, valued at
$207.9k
Paid exercise price by delivering 312 shares
@ $691.31, valued at
$215.7k
Exercised 400 options to buy
@ $381.92, valued at
$152.8k
|
|
| 03/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2021 |
4
| Landry Robert E (EVP Finance CFO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 3,069 shares
@ $651.97, valued at
$2M
Sold 681 shares
@ $645.08, valued at
$439.3k
Exercised 3,750 options to buy
@ $399.66, valued at
$1.5M
|
|
| 09/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/11/2020 |
4
| Landry Robert E (EVP Finance CFO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Granted 1,930 shares
@ $0
Granted 19,950 options to buy
@ $492, valued at
$9.8M
|
|
| 08/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2020 |
4
| Landry Robert E (EVP Finance CFO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 8,388 shares
@ $626.19, valued at
$5.3M
Sold 40 shares
@ $624.65, valued at
$25k
Sold 56 shares
@ $626.56, valued at
$35.1k
Sold 39 shares
@ $628.64, valued at
$24.5k
Sold 82 shares
@ $630.84, valued at
$51.7k
Sold 78 shares
@ $631.25, valued at
$49.2k
Sold 82 shares
@ $633.56, valued at
$52k
Sold 89 shares
@ $634.63, valued at
$56.5k
Sold 46 shares
@ $635.24, valued at
$29.2k
Exercised 8,900 options to buy
@ $555.67, valued at
$4.9M
|
|
| 06/12/2020 |
4
| Landry Robert E (EVP Finance CFO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 2,512 shares
@ $610.18, valued at
$1.5M
Sold 445 shares
@ $607.5, valued at
$270.3k
Sold 65 shares
@ $608.91, valued at
$39.6k
Sold 14 shares
@ $611.82, valued at
$8.6k
Sold 177 shares
@ $612.74, valued at
$108.5k
Sold 23 shares
@ $613.53, valued at
$14.1k
Sold 34 shares
@ $614.41, valued at
$20.9k
Sold 31 shares
@ $616, valued at
$19.1k
Sold 66 shares
@ $619.73, valued at
$40.9k
Sold 58 shares
@ $620.7, valued at
$36k
Sold 16 shares
@ $621.56, valued at
$9.9k
|
|
| 06/10/2020 |
4
| Landry Robert E (EVP Finance CFO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 2,536 shares
@ $592.43, valued at
$1.5M
Paid exercise price by delivering 1,811 shares
@ $592.4, valued at
$1.1M
Paid exercise price by delivering 1,630 shares
@ $592.43, valued at
$965.7k
Paid exercise price by delivering 1,086 shares
@ $592.43, valued at
$643.4k
Sold 110 shares
@ $602.38, valued at
$66.3k
Sold 131 shares
@ $603.68, valued at
$79.1k
Sold 50 shares
@ $604.14, valued at
$30.2k
Sold 289 shares
@ $605.14, valued at
$174.9k
Sold 353 shares
@ $606.79, valued at
$214.2k
Sold 619 shares
@ $607.47, valued at
$376k
Sold 1,511 shares
@ $608.5, valued at
$919.4k
|
|
| 04/20/2020 |
4
| Landry Robert E (EVP Finance CFO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 3,009 shares
@ $529.79, valued at
$1.6M
Sold 33 shares
@ $540.7, valued at
$17.8k
Sold 33 shares
@ $542.25, valued at
$17.9k
Sold 61 shares
@ $548.99, valued at
$33.5k
Sold 3 shares
@ $550, valued at
$1.7k
Sold 55 shares
@ $551.38, valued at
$30.3k
Sold 62 shares
@ $553.85, valued at
$34.3k
Sold 33 shares
@ $556.43, valued at
$18.4k
Sold 89 shares
@ $558.63, valued at
$49.7k
Sold 155 shares
@ $559.25, valued at
$86.7k
Sold 232 shares
@ $560.31, valued at
$130k
|
|
| 04/16/2020 |
4
| Landry Robert E (EVP Finance CFO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 2,647 shares
@ $521.45, valued at
$1.4M
Sold 54 shares
@ $516.89, valued at
$27.9k
Sold 304 shares
@ $517.84, valued at
$157.4k
Sold 287 shares
@ $518.31, valued at
$148.8k
Sold 76 shares
@ $519.58, valued at
$39.5k
Sold 130 shares
@ $520.36, valued at
$67.6k
Sold 2 shares
@ $525.3, valued at
$1.1k
Exercised 3,500 options to buy
@ $272.7, valued at
$954.5k
|
|
| 04/13/2020 |
4
| Landry Robert E (EVP Finance CFO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 2,672 shares
@ $508.25, valued at
$1.4M
Sold 99 shares
@ $505.6, valued at
$50.1k
Sold 38 shares
@ $506.24, valued at
$19.2k
Sold 30 shares
@ $507.45, valued at
$15.2k
Sold 115 shares
@ $508.54, valued at
$58.5k
Sold 170 shares
@ $509.45, valued at
$86.6k
Sold 143 shares
@ $510.43, valued at
$73k
Sold 156 shares
@ $511.59, valued at
$79.8k
Sold 31 shares
@ $512.58, valued at
$15.9k
Sold 46 shares
@ $517.71, valued at
$23.8k
Exercised 3,500 options to buy
@ $272.7, valued at
$954.5k
|
|
| 04/08/2020 |
4
| Landry Robert E (EVP Finance CFO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 2,304 shares
@ $499.95, valued at
$1.2M
Sold 694 shares
@ $497.5, valued at
$345.3k
Sold 2 shares
@ $502.81, valued at
$1k
Exercised 3,000 options to buy
@ $272.7, valued at
$818.1k
|
|
| 04/03/2020 |
4
| Landry Robert E (EVP Finance CFO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 69 shares
@ $495.24, valued at
$34.2k
Sold 11 shares
@ $496.28, valued at
$5.5k
Sold 25 shares
@ $497.48, valued at
$12.4k
Sold 121 shares
@ $489.5, valued at
$59.2k
Sold 50 shares
@ $490.66, valued at
$24.5k
Sold 25 shares
@ $492.76, valued at
$12.3k
Sold 99 shares
@ $493.51, valued at
$48.9k
Sold 172 shares
@ $494.42, valued at
$85k
Sold 2 shares
@ $495.56, valued at
$991.1
Sold 54 shares
@ $496.33, valued at
$26.8k
Sold 25 shares
@ $497.6, valued at
$12.4k
|
|
| 04/03/2020 |
4
| Landry Robert E (EVP Finance CFO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 23 shares
@ $478.97, valued at
$11k
Sold 75 shares
@ $479.5, valued at
$36k
Sold 87 shares
@ $481.91, valued at
$41.9k
Sold 1 shares
@ $484.14, valued at
$484.1
Sold 23 shares
@ $486.27, valued at
$11.2k
Sold 23 shares
@ $488.77, valued at
$11.2k
Sold 61 shares
@ $489.46, valued at
$29.9k
Sold 87 shares
@ $490.7, valued at
$42.7k
Sold 64 shares
@ $492.61, valued at
$31.5k
Sold 156 shares
@ $493.08, valued at
$76.9k
Exercised 2,500 shares
@ $272.7, valued at
$681.8k
|
|
| 02/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|